News for 'Diagnostic'

Cadila launches Remdesivir in India at Rs 2,800 per vial

Cadila launches Remdesivir in India at Rs 2,800 per vial

Rediff.com13 Aug 2020

The company said the drug will be made available across India through the group's strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.

Made-in-India Covaxin gets WHO's emergency use licence

Made-in-India Covaxin gets WHO's emergency use licence

Rediff.com3 Nov 2021

Covaxin was found to have 78 per cent efficacy against COVID-19 of any severity, 14 or more days after the second dose, and is extremely suitable for low- and middle-income countries due to easy storage requirements, said the global health body.

Bengal announces complete lockdown from May 16-30 to curb Covid spread

Bengal announces complete lockdown from May 16-30 to curb Covid spread

Rediff.com15 May 2021

During this period, all government and private offices, shopping complexes, malls, bars, sports complexes, pubs and beauty parlours will remain closed.

WHO classifies Indian Covid strain as 'variant of concern'

WHO classifies Indian Covid strain as 'variant of concern'

Rediff.com11 May 2021

The B-1617 variant of the coronavirus, first identified in India, has been classified as a variant of concern at the global level by the World Health Organisation (WHO).

'Investors should allocate more towards large-caps and defensives in the current risk-off scenario'

'Investors should allocate more towards large-caps and defensives in the current risk-off scenario'

Rediff.com13 May 2022

'For the next two years, we expect the bulk of earnings growth contribution from sectors like financials and energy, where the outlook remains positive, while the sectors which are linked to domestic consumption and are currently witnessing strains on margins have low salience for Nifty earnings.'

Revealed: How India launched its war against COVID-19

Revealed: How India launched its war against COVID-19

Rediff.com30 Jul 2020

'The lockdown was for both: To flatten the curve or more correctly, delay the rapid spread of COVID outbreak, and to create healthcare infrastructure.'

Fortis plans to list SRL in 2011

Fortis plans to list SRL in 2011

Rediff.com2 Sep 2010

Fortis Healthcare Chairman Malvinder Mohan Singh on Wednesday said it planned to launch an IPO for its diagnostics business unit, Super Religare Laboratories (SRL), in 2011. SRL had acquired the diagnostics business of Piramal Healthcare for Rs 600 crore in the first quarter of this financial year.

About 18-19 COVID vaccine candidates in pipeline: Harsh Vardhan

About 18-19 COVID vaccine candidates in pipeline: Harsh Vardhan

Rediff.com15 Feb 2021

About 18-19 coronavirus vaccine candidates are in different clinical trial stages and may be available in the coming months, Health Minister Harsh Vardhan said on Monday.

Second round of sero survey begins in Mumbai

Second round of sero survey begins in Mumbai

Rediff.com10 Aug 2020

The study will provide information about the spread of the infection and also throw light on herd immunity.

TB testing machine to be used for COVID-19: ICMR

TB testing machine to be used for COVID-19: ICMR

Rediff.com20 May 2020

A total of 25,12,388 samples have been tested for coronavirus infection as on 9 am, May 20 all over the country.

COVID-19: France, US deliver oxygen supplies to India

COVID-19: France, US deliver oxygen supplies to India

Rediff.com2 May 2021

France on Sunday delivered to India 28 tonnes of ready-to-use medical supplies including eight large oxygen plants while the US sent to India a third flight that brought over 1000 oxygen cylinders

Trump 'safe' to return to public life on Saturday: Doc

Trump 'safe' to return to public life on Saturday: Doc

Rediff.com9 Oct 2020

Since returning home, his physical exam has remained stable and devoid of any indications to suggest progression of illness, his doctor said.

WHO chief thanks PM for support to global COVID response

WHO chief thanks PM for support to global COVID response

Rediff.com23 Jan 2021

Prime Minister Modi has said India's vaccine production and delivery capacity will be used for the benefit of all humanity to fight the COVID-19 pandemic. He said last week India was ready to do everything possible for a healthy planet.

6 flyers from 'at-risk' countries admitted to Delhi's LNJP Hospital

6 flyers from 'at-risk' countries admitted to Delhi's LNJP Hospital

Rediff.com2 Dec 2021

Six Covid-19 cases were reported on Wednesday after screening 3,476 passengers of 11 flights that arrived in India from "at-risk" countries and the samples have been sent for genomic sequencing, the Health Ministry said amid concerns over the 'Omicron' variant of coronavirus.

Tata Motors launches Tigor EV @ Rs 11.99 lakh

Tata Motors launches Tigor EV @ Rs 11.99 lakh

Rediff.com31 Aug 2021

Tata Motors on Tuesday launched its second electric vehicle -- Tigor EV, catering to the personal segment in the domestic market, priced between Rs 11.99 lakh and Rs 13.14 lakh (ex-showroom). The model comes in three variants, priced at Rs 11.99 lakh, Rs 12.49 lakh and Rs 12.99 lakh. A dual tone top-end trim is tagged at Rs 13.14 lakh. The auto major has already achieved success with its first electric model, Nexon EV and now commences deliveries of Tigor EV from around 150 sales outlets in 70 cities across the country.

Infosys partners NovaSom to offer cloud-based user portal

Infosys partners NovaSom to offer cloud-based user portal

Rediff.com16 Jan 2013

The new portal provides physicians with a single, easy-to-use interface that speeds up the order-to-delivery of devices, processing of diagnostic data and management of insurance claims.

Budget 2022: Insurers want investment limit of 80C hiked

Budget 2022: Insurers want investment limit of 80C hiked

Rediff.com26 Jan 2022

Insurance companies are seeking a separate deduction limit of Rs 1 lakh for insurance premium payment under Section 80C of the Income Tax Act in the upcoming Union Budget to bring in more people under the ambit of insurance. The insurers also want reduction in the goods and services tax (GST) rate of 18 per cent currently applied on health insurance products to 5 per cent to make such products more affordable to common people. Finance Minister Nirmala Sitharaman will present the Union Budget for 2022-23 on February 1.

Over 5 crore COVID-19 tests conducted till date in India

Over 5 crore COVID-19 tests conducted till date in India

Rediff.com8 Sep 2020

The average Tests Per Million Per Day have increased from 237 in the second week of July to 758 in the first week of September.

Hospitals not in the pink of health amid Covid-19 crisis

Hospitals not in the pink of health amid Covid-19 crisis

Rediff.com6 Jul 2020

The COVID-19 pandemic has not only affected outpatient services, but also led to deferment of elective surgeries, and resulted in the loss of medical tourism, all of which would hit the FY21 financials.

Revealed: Our Banks' Financial Health

Revealed: Our Banks' Financial Health

Rediff.com12 May 2022

We'll need to wait a couple of years to see how many restructured loans turn bad and whether some banks fall victim to their obsession for growth, explains Tamal Bandyopadhyay.

India crosses crucial milestone of 10 lakh COVID-19 tests per day

India crosses crucial milestone of 10 lakh COVID-19 tests per day

Rediff.com22 Aug 2020

As has been reported from states and UTs that have pushed ahead with aggressive testing, there is a commensurate decline in the positivity rate, the health ministry said.

Bharat Benz use data to up its service quotient

Bharat Benz use data to up its service quotient

Rediff.com15 Nov 2018

New age diagnostic tools come in handy for BharatBenz to predict repair needs and breakdown in advance.

Metropolis Healthcare's Rs 1,200-cr IPO to open on Apr 3

Metropolis Healthcare's Rs 1,200-cr IPO to open on Apr 3

Rediff.com29 Mar 2019

The offering comprises secondary sale of 13.68 million shares, constituting 27.3 per cent stake.

5 more manufacturers to produce black fungus drug: Govt

5 more manufacturers to produce black fungus drug: Govt

Rediff.com21 May 2021

The Union health ministry on Friday said license has been given to five more manufacturers for production of Amphotericin-B, used in the treatment of black fungus, and they will start producing 1,11,000 vials of the drug per month from July.

45% of Mumbai slum dwellers exposed to Covid: Survey

45% of Mumbai slum dwellers exposed to Covid: Survey

Rediff.com2 Oct 2020

The survey was carried out in wards R-north (Borivali), M-West (Mankhurd and Govandi) and F-North (Worli and Lower Parel) in the second half of August.

Meet Adar Poonawala, India's COVID-19 vaccine man

Meet Adar Poonawala, India's COVID-19 vaccine man

Rediff.com6 Aug 2020

Serum Institute is investing $200 million to create capacities for the COVID-19 vaccine. Sohini Das profiles its 39-year-old CEO.

Driverless train operations flagged off on Delhi Metro's Pink Line

Driverless train operations flagged off on Delhi Metro's Pink Line

Rediff.com25 Nov 2021

In another milestone for the DMRC, driverless train operations on 59-km Pink Line of the Delhi Metro were flagged off on Thursday.

No one safe until all vaccinated for Covid: Johns Hopkins scientist

No one safe until all vaccinated for Covid: Johns Hopkins scientist

Rediff.com22 Apr 2022

Vaccine inequity remains an issue in India, where less than 2 per cent of the population has received a Covid booster

Now clinical research opts for outsourcing

Now clinical research opts for outsourcing

Rediff.com5 May 2008

After business, knowledge and legal process outsourcing, the Indian industries are now eyeing 'diagnostics jobs' outsourcing from other countries. According to industry experts, a number of hospitals in the US and Europe are outsourcing laboratory and diagnostic tests to India as it helps in saving cost and money while maintaining quality.

A Russian train on a unique mission!

A Russian train on a unique mission!

Rediff.com30 May 2014

This train in Russia is a free consultative and diagnostic medical centre.

Relocating tents, keeping farm movement memories alive

Relocating tents, keeping farm movement memories alive

Rediff.com10 Dec 2021

As the farmers prepare to leave their protest sites on Delhi's borders on Saturday after the government repealed the farm laws and acceded to their other demands, many say they will reinstall their tents in their villages as a symbol of their long, arduous struggle.

Recovered cases exceed active cases by over 1 lakh

Recovered cases exceed active cases by over 1 lakh

Rediff.com28 Jun 2020

"The recovery rate is 58.56 per cent amongst COVID-19 patients," the ministry said.

With Hanuman image, Brazil Prez thanks PM Modi for COVID vaccines

With Hanuman image, Brazil Prez thanks PM Modi for COVID vaccines

Rediff.com23 Jan 2021

PM Modi said that it was an honour to be a trusted partner during the pandemic adding that the two countries will continue to strengthen cooperation on healthcare.

Gennova's mRNA vaccine to come in powder form, stay stable at 2-8C

Gennova's mRNA vaccine to come in powder form, stay stable at 2-8C

Rediff.com14 Sep 2021

Gennova has also got permission for phase-2 and 3 clinical trials for its lyophilised mRNA vaccine for injection from the subject expert committee advising the Central Drugs Standards Control Organisation, reports Sohini Das.

Deaths in Covid 3rd wave much lower than in 2nd wave, says govt

Deaths in Covid 3rd wave much lower than in 2nd wave, says govt

Rediff.com20 Jan 2022

Deaths are significantly less in the third wave of the Covid-19 pandemic in comparison to the second wave, and the current surge is not witnessing increase in severe illness or death following high vaccination uptake, the government said on Thursday.

Want to invest in Healthcare ETFs?

Want to invest in Healthcare ETFs?

Rediff.com4 Jun 2021

If a retail investor wants exposure to a healthcare ETF, it should be a part of his satellite portfolio, suggests Sanjay Kumar Singh.

COVID scare: England at risk from Euro 2020 euphoria

COVID scare: England at risk from Euro 2020 euphoria

Rediff.com9 Jul 2021

Although British Prime Minister Boris Johnson has delayed the full reopening of England's economy until July 19, a week after the final, people can still gather in bars and pubs. Jubilant fans were pictured packing bars, streets and even clambering on top of a London bus in the aftermath of England's extra-time 2-1 victory over Denmark, with fan-zones highlighted by some as a particular risk for transmission.

NSE technical glitch cost us immensely, says FM Nirmala Sitharaman

NSE technical glitch cost us immensely, says FM Nirmala Sitharaman

Rediff.com2 Mar 2021

Taking lessons from that, I would think seamless digital payments is something you have to clearly have a roadmap for, the FM said.

Railways to set up 522 hospitals

Railways to set up 522 hospitals

Rediff.com24 Feb 2010

Presenting the Railway Budget for 2010-11 in Parliament, the minister said outpatient departments and diagnostic centres will be set up in several stations across India.

Dream run to continue for small- and mid-cap stocks

Dream run to continue for small- and mid-cap stocks

Rediff.com9 Aug 2021

The relentless rally in small- and mid-cap stocks continues as large-caps show signs of fatigue. In July, the Nifty Smallcap 100 rose 8.1 per cent, extending its year-to-date (YTD) gains to 48.5 per cent, while the Nifty Midcap 100 added 3.1 per cent, taking its YTD rise to 33.5 per cent. On the other hand, the Nifty50 remained unchanged for the month, with YTD gains of 12.7 per cent.